Johann Riedemann

971 total citations
13 papers, 758 citations indexed

About

Johann Riedemann is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Johann Riedemann has authored 13 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Johann Riedemann's work include Growth Hormone and Insulin-like Growth Factors (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and RNA Interference and Gene Delivery (2 papers). Johann Riedemann is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (3 papers), Endometrial and Cervical Cancer Treatments (2 papers) and RNA Interference and Gene Delivery (2 papers). Johann Riedemann collaborates with scholars based in South Africa, United Kingdom and Russia. Johann Riedemann's co-authors include Valentine M. Macaulay, A. J. Salisbury, Edwin M. Southern, Muhammad Sohail, Erin A. Bohula, Martin P. Playford, Simon Brewster, Mark Rochester, Giles Hellawell and Janet P. Hapgood and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Cytokine & Growth Factor Reviews.

In The Last Decade

Johann Riedemann

12 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johann Riedemann South Africa	9	569	231	199	134	70	13	758
M Remacle-Bonnet France	18	457 0.8×	382 1.7×	240 1.2×	189 1.4×	111 1.6×	35	886
Sébastien Soubeyrand Canada	18	520 0.9×	61 0.3×	119 0.6×	152 1.1×	112 1.6×	37	832
G. Pommier France	11	242 0.4×	169 0.7×	97 0.5×	92 0.7×	60 0.9×	24	465
Kathleen C. Lee United States	12	504 0.9×	313 1.4×	83 0.4×	227 1.7×	166 2.4×	14	863
Daisuke Yamaji Japan	13	289 0.5×	61 0.3×	95 0.5×	287 2.1×	108 1.5×	21	648
Jun Seop Yun South Korea	13	310 0.5×	80 0.3×	67 0.3×	50 0.4×	132 1.9×	20	513
Bart Westendorp Netherlands	16	604 1.1×	29 0.1×	167 0.8×	270 2.0×	79 1.1×	41	869
Laura Tsujikawa United States	13	550 1.0×	79 0.3×	48 0.2×	69 0.5×	140 2.0×	33	700
Miaojun Han United States	9	225 0.4×	35 0.2×	153 0.8×	182 1.4×	52 0.7×	10	738
James E. Tate United States	14	288 0.5×	82 0.4×	127 0.6×	168 1.3×	76 1.1×	16	805

Countries citing papers authored by Johann Riedemann

Since Specialization

Citations

This map shows the geographic impact of Johann Riedemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johann Riedemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johann Riedemann more than expected).

Fields of papers citing papers by Johann Riedemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johann Riedemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johann Riedemann. The network helps show where Johann Riedemann may publish in the future.

Co-authorship network of co-authors of Johann Riedemann

This figure shows the co-authorship network connecting the top 25 collaborators of Johann Riedemann. A scholar is included among the top collaborators of Johann Riedemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johann Riedemann. Johann Riedemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Riedemann, Johann, et al.. (2025). Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response. Seminars in Oncology. 52(4). 152352–152352.

Chellan, Nireshni, et al.. (2025). Personalised Medicine in Cervical Cancer: Evaluating Therapy Resistance Through Multi‐Model Approaches. Cancer Medicine. 14(13). e70995–e70995. 1 indexed citations

Riedemann, Johann, et al.. (2024). A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer. Cancer Control. 31. 2925679587–2925679587. 1 indexed citations

Riedemann, Johann, et al.. (2024). Highlighting the role of CD44 in cervical cancer progression: immunotherapy’s potential in inhibiting metastasis and chemoresistance. Immunologic Research. 72(4). 592–604. 7 indexed citations

Fourie, C.M.T., et al.. (2021). Cancer and Covid-19: Collectively catastrophic. Cytokine & Growth Factor Reviews. 63. 78–89. 17 indexed citations

Turney, Benjamin W., Martin Kerr, Meenali Chitnis, et al.. (2012). Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks. Radiotherapy and Oncology. 103(3). 402–409. 37 indexed citations

Loos, Ben, et al.. (2011). Myomegalin is a novel A-kinase anchoring protein involved in the phosphorylation of cardiac myosin binding protein C. BMC Cell Biology. 12(1). 18–18. 48 indexed citations

Riedemann, Johann, et al.. (2007). The EGF receptor interacts with the type 1 IGF receptor and regulates its stability. Biochemical and Biophysical Research Communications. 355(3). 707–714. 57 indexed citations

Riedemann, Johann, Muhammad Sohail, & Valentine M. Macaulay. (2007). Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells. Biochemical and Biophysical Research Communications. 355(3). 700–706. 24 indexed citations

10.

Riedemann, Johann & Valentine M. Macaulay. (2006). IGF1R signalling and its inhibition. Endocrine Related Cancer. 13(Supplement_1). S33–S43. 232 indexed citations

11.

Rochester, Mark, Johann Riedemann, Giles Hellawell, Simon Brewster, & Valentine M. Macaulay. (2004). Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Therapy. 12(1). 90–100. 93 indexed citations

12.

Bohula, Erin A., A. J. Salisbury, Muhammad Sohail, et al.. (2003). The Efficacy of Small Interfering RNAs Targeted to the Type 1 Insulin-like Growth Factor Receptor (IGF1R) Is Influenced by Secondary Structure in the IGF1R Transcript. Journal of Biological Chemistry. 278(18). 15991–15997. 194 indexed citations

13.

Hapgood, Janet P., et al.. (2001). REGULATION OF GENE EXPRESSION BY GC‐RICH DNA CIS ‐ELEMENTS. Cell Biology International. 25(1). 17–31. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact